159 related articles for article (PubMed ID: 14636162)
1. Role of interferon-gamma and nitric oxide in the neuropathogenesis of avirulent Semliki Forest virus infection.
Keogh B; Atkins GJ; Mills KH; Sheahan BJ
Neuropathol Appl Neurobiol; 2003 Dec; 29(6):553-62. PubMed ID: 14636162
[TBL] [Abstract][Full Text] [Related]
2. Avirulent Semliki Forest virus replication and pathology in the central nervous system is enhanced in IL-12-defective and reduced in IL-4-defective mice: a role for Th1 cells in the protective immunity.
Keogh B; Atkins GJ; Mills KH; Sheahan BJ
J Neuroimmunol; 2002 Apr; 125(1-2):15-22. PubMed ID: 11960636
[TBL] [Abstract][Full Text] [Related]
3. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase.
Hölscher C; Köhler G; Müller U; Mossmann H; Schaub GA; Brombacher F
Infect Immun; 1998 Mar; 66(3):1208-15. PubMed ID: 9488415
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of matrix metalloproteinases ameliorates blood-brain barrier disruption and neuropathological lesions caused by avirulent Semliki Forest virus infection.
Keogh B; Sheahan BJ; Atkins GJ; Mills KH
Vet Immunol Immunopathol; 2003 Aug; 94(3-4):185-90. PubMed ID: 12909414
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection.
Morris MM; Dyson H; Baker D; Harbige LS; Fazakerley JK; Amor S
J Neuroimmunol; 1997 Apr; 74(1-2):185-97. PubMed ID: 9119972
[TBL] [Abstract][Full Text] [Related]
6. Cell death mechanisms in the olfactory bulb of rats infected intranasally with Semliki forest virus.
Sammin DJ; Butler D; Atkins GJ; Sheahan BJ
Neuropathol Appl Neurobiol; 1999 Jun; 25(3):236-43. PubMed ID: 10417665
[TBL] [Abstract][Full Text] [Related]
7. The type I interferon system protects mice from Semliki Forest virus by preventing widespread virus dissemination in extraneural tissues, but does not mediate the restricted replication of avirulent virus in central nervous system neurons.
Fragkoudis R; Breakwell L; McKimmie C; Boyd A; Barry G; Kohl A; Merits A; Fazakerley JK
J Gen Virol; 2007 Dec; 88(Pt 12):3373-3384. PubMed ID: 18024907
[TBL] [Abstract][Full Text] [Related]
8. Role of γδ T cells in antibody production and recovery from SFV demyelinating disease.
Safavi F; Feliberti JP; Raine CS; Mokhtarian F
J Neuroimmunol; 2011 Jun; 235(1-2):18-26. PubMed ID: 21612829
[TBL] [Abstract][Full Text] [Related]
9. Role of interferon-gamma in T-cell responses to Semliki Forest virus-infected murine brain cells.
Tomkins PT; Ward GA; Morris AG
Immunology; 1988 Mar; 63(3):355-62. PubMed ID: 2832313
[TBL] [Abstract][Full Text] [Related]
10. In Semliki Forest virus encephalitis, antibody rapidly clears infectious virus and is required to eliminate viral material from the brain, but is not required to generate lesions of demyelination.
Fragkoudis R; Ballany CM; Boyd A; Fazakerley JK
J Gen Virol; 2008 Oct; 89(Pt 10):2565-2568. PubMed ID: 18796725
[TBL] [Abstract][Full Text] [Related]
11. Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal.
Chakour R; Guler R; Bugnon M; Allenbach C; Garcia I; Mauël J; Louis J; Tacchini-Cottier F
Infect Immun; 2003 Sep; 71(9):5287-95. PubMed ID: 12933876
[TBL] [Abstract][Full Text] [Related]
12. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
Yap GS; Sher A
J Exp Med; 1999 Apr; 189(7):1083-92. PubMed ID: 10190899
[TBL] [Abstract][Full Text] [Related]
13. Inducible nitric oxide synthase expression elicited in the mouse brain by inflammatory mediators circulating in the cerebrospinal fluid.
Kong GY; Peng ZC; Costanzo C; Kristensson K; Bentivoglio M
Brain Res; 2000 Sep; 878(1-2):105-18. PubMed ID: 10996141
[TBL] [Abstract][Full Text] [Related]
14. Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction.
Eriksson U; Kurrer MO; Bingisser R; Eugster HP; Saremaslani P; Follath F; Marsch S; Widmer U
Circulation; 2001 Jan; 103(1):18-21. PubMed ID: 11136679
[TBL] [Abstract][Full Text] [Related]
15. Semliki Forest virus-induced demyelination and remyelination--involvement of B cells and anti-myelin antibodies.
Mokhtarian F; Huan CM; Roman C; Raine CS
J Neuroimmunol; 2003 Apr; 137(1-2):19-31. PubMed ID: 12667644
[TBL] [Abstract][Full Text] [Related]
16. Mice deficient in interferon-gamma or interferon-gamma receptor 1 have distinct inflammatory responses to acute viral encephalomyelitis.
Lee EY; Schultz KL; Griffin DE
PLoS One; 2013; 8(10):e76412. PubMed ID: 24204622
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-4-mediated inhibition of nitric oxide production in interferon-gamma-treated and virus-infected macrophages.
Paludan SR; Ellermann-Eriksen S; Lovmand J; Mogensen SC
Scand J Immunol; 1999 Feb; 49(2):169-76. PubMed ID: 10075021
[TBL] [Abstract][Full Text] [Related]
18. Role of inducible nitric oxide synthase-derived nitric oxide in lipopolysaccharide plus interferon-gamma-induced pulmonary inflammation.
Zeidler PC; Millecchia LM; Castranova V
Toxicol Appl Pharmacol; 2004 Feb; 195(1):45-54. PubMed ID: 14962504
[TBL] [Abstract][Full Text] [Related]
19. PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response.
Barry G; Breakwell L; Fragkoudis R; Attarzadeh-Yazdi G; Rodriguez-Andres J; Kohl A; Fazakerley JK
J Gen Virol; 2009 Jun; 90(Pt 6):1382-1391. PubMed ID: 19264662
[TBL] [Abstract][Full Text] [Related]
20. Selective downregulation of Th1 response by Linomide reduces autoimmunity but increases susceptibility to viral infection in BALB/c and SJL mice.
Erälinna JP; Röyttä M; Hukkanen V; Zinhu D; Salmi AA; Salonen R
J Neuroimmunol; 1998 Aug; 88(1-2):165-76. PubMed ID: 9688338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
